Sai Life Sciences Ltd (SAILIFE) — Corporate Action | 1 September 2026

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Allotment of 80,600 shares under ESOP 2008 and MESOP 2018
🔄 What Changed
Paid-up capital increased from ₹21,23,13,617 to ₹21,23,94,216
💡 Investor Takeaway
Share allotment dilutes existing shareholders' ownership proportionally.

Sai Life Sciences announced allotment of 80,600 equity shares under its ESOP 2008 and MESOP 2018 plans on 01 September 2026, allotting 14,600 shares at ₹188.90 exercise price and 66,000 shares at ₹23.30 exercise price. The allotment increased the paid-up capital from ₹21,23,13,617 to ₹21,23,94,216. The shares are fully paid-up with a face value of ₹1 each and are identical to existing shares. No lock-in applies.

📄 View Original Announcement (PDF)

About Sai Life Sciences Ltd (SAILIFE)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹32,244.12 Cr P/E: 88.5 ROE: 14.6% ROCE: 20.1%

View full SAILIFE stock details →

📡 Get AI alerts when SAILIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SAILIFE — Free

📊 More SAILIFE filings

See all SAILIFE filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SAILIFE files new disclosures

Track SAILIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SAILIFE — Free

Free account · 2 AI queries/day